Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.93.25 CHF
Change Today -1.50 / -1.58%
Volume 6.4K
HBMN On Other Exchanges
SIX Swiss Ex
As of 11:43 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jack Obijeski Ph.D.

AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 4 different industries.

See Board Relationships


Dr. John F. Obijeski, Jack, Ph.D. serves as Special Advisor for Scientific & Corporate Development of Presidio Pharmaceuticals Inc. Dr. Obijeski was an Investment Advisor of HBM BioVentures AG. He has more than 30 years of experience in microbiology, virology and biotechnology. Dr. Obijeski served as the Vice President of Business Development and Scientific Affairs of Genitope Corp. He was associated with Genentech, Inc., for over 15 years and served as Director of Vaccine ...

Read Full Background

Corporate Headquarters*

Bundesplatz 1
Zug, Zug 6301


Phone: 41 41 768 11 08
Fax: 41 41 768 11 09

Board Members Memberships*



University of Connecticut
Waksman Institute of Microbiology, Rutgers University
Waksman Institute of Microbiology, Rutgers University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HBMN:SW SFr.93.25 CHF -1.50


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HBM BIOVENTURES AG-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at